Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage clinical pipeline support.
Biogen Bets Big On $2 Billion Expansion To Boost US Drug Manufacturing
Where Today's News Shapes Tomorrow
